| Original Research Online Published: 11 Dec 2021 | ||||||||||||||||||||||||||||||
A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia Veena H, Narendranath S, Vinay S Yeli.
| ||||||||||||||||||||||||||||||
| How to Cite this Article |
| Pubmed Style H V, S N, Yeli VS. A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 93-96. doi:10.5455/njppp.2022.12.12434202105122021 Web Style H V, S N, Yeli VS. A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. https://www.njppp.com/?mno=34572 [Access: January 18, 2025]. doi:10.5455/njppp.2022.12.12434202105122021 AMA (American Medical Association) Style H V, S N, Yeli VS. A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 93-96. doi:10.5455/njppp.2022.12.12434202105122021 Vancouver/ICMJE Style H V, S N, Yeli VS. A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. Natl J Physiol Pharm Pharmacol. (2022), [cited January 18, 2025]; 12(1): 93-96. doi:10.5455/njppp.2022.12.12434202105122021 Harvard Style H, V., S, . N. & Yeli, . V. S. (2022) A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. Natl J Physiol Pharm Pharmacol, 12 (1), 93-96. doi:10.5455/njppp.2022.12.12434202105122021 Turabian Style H, Veena, Narendranath S, and Vinay S Yeli. 2022. A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. National Journal of Physiology, Pharmacy and Pharmacology, 12 (1), 93-96. doi:10.5455/njppp.2022.12.12434202105122021 Chicago Style H, Veena, Narendranath S, and Vinay S Yeli. "A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 93-96. doi:10.5455/njppp.2022.12.12434202105122021 MLA (The Modern Language Association) Style H, Veena, Narendranath S, and Vinay S Yeli. "A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia." National Journal of Physiology, Pharmacy and Pharmacology 12.1 (2022), 93-96. Print. doi:10.5455/njppp.2022.12.12434202105122021 APA (American Psychological Association) Style H, V., S, . N. & Yeli, . V. S. (2022) A prospective observational open-label study to evaluate the effect of telmisartan on glycosylated hemoglobin and fasting plasma glucose levels in hypertensive patients with impaired fasting glycaemia. National Journal of Physiology, Pharmacy and Pharmacology, 12 (1), 93-96. doi:10.5455/njppp.2022.12.12434202105122021 |
